Replies to post #43017 on Titan Medical Inc (TMDIF)

[investinthefuture]

This is better news than I expected. The fact that Longtai wants to retain its exclusive right to negotiate a distribution agreement with Titan for Asia-Pacific suggests that they know enough to know that this is not yet a lost cause. The press release that I was expecting was that Titan and Longtai had ended their negotiations, and that the initial investment had been returned.

[devicerep888]

The month to month reviews are to ensure that Titan updates Longtai on progress with a partnership, IMO.

If you are JNJ/Verb, Stryker, CR Bard, Medtronic, or whatever other company that has been looking to get into surgical robotics, the price has never been cheaper. What a perfect time to step in and save the day, get a sweet deal, and get this product to CE and FDA approval. The right partner will provide instant distribution, sales relationships, contract (GPO) status, service organizations, applications teams, etc..You can start selling and running a business!!

JH should be selling Titan harder than he ever has, he has a lot to sell and price has never been better with being this close to design freeze. Big companies need growth and they need new products, and they have $$ and the infrastructure to convert from product to sales quickly. They also have relationships at the FDA and know how the FDA works. This could be the most valuable part of a partnership in the end. Who's to say Medtronic wouldn't want to add another robot to its portfolio?

Common JH come through for us on this one!! Get a deal done!!